![Robin Meister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robin Meister
Corporate Officer/Principal bei
AURINIA PHARMACEUTICALS INC.
Profil
Robin Meister is currently Vice President-Finance at Aurinia Pharmaceuticals, Inc., a position held since 2020.
Formerly, Ms. Meister was Vice President-Internal Audit at U.S.
Silica Holdings, Inc. from 2014 to 2020 and Associate Director-Americas Internal Audit at QIAGEN NV from 2005 to 2014.
Ms. Meister completed undergraduate education at the University of Maryland.
Aktive Positionen von Robin Meister
| Unternehmen | Position | Beginn |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.08.2020 |
Ehemalige bekannte Positionen von Robin Meister
| Unternehmen | Position | Ende |
|---|---|---|
| U.S. SILICA HOLDINGS, INC. | Comptroller/Controller/Auditor | 01.01.2020 |
| QIAGEN N.V. | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Robin Meister
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
44
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
U.S. Silica Holdings, Inc.
 U.S. Silica Holdings, Inc. Construction MaterialsNon-Energy Minerals Produces commercial silica | Non-Energy Minerals |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
